×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| KREBS BIOCHEMICALS & INDUSTRIE | 64.39 | -82.68 | 61.01 | -3.83 | 189.0 | |
| BDH INDUSTRIES LTD. | 183.96 | 24.89 | 178.22 | 4.33 | 182 | 19.6 |
| AAREY DRUGS & PHARMACEUTICALS | 1,156.37 | 4.70 | 1,080.99 | 0.02 | 176 | 43.8 |
Krebs Biochemicals & Industries Ltd., with Security Code 524518, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.1 | 11.5 | 10.6 | 14.9 | 13.0 | 12.0 | 12.9 | 12.9 | 11.5 | 6.1 |
| Expenses | 12.1 | 16.1 | 13.2 | 15.8 | 15.1 | 15.1 | 15.1 | 15.6 | 16.2 | 11.4 |
| Operating Profit | -3.0 | -4.6 | -2.6 | -0.9 | -2.1 | -3.1 | -2.2 | -2.7 | -4.7 | -5.3 |
| OPM % | -32.85% | -40.35% | -24.77% | -6.05% | -16.11% | -26% | -17.04% | -21.08% | -41.13% | -87.12% |
| Other Income | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.1 | 0.3 | 0.3 |
| Interest | 0.9 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 | 1.6 |
| Depreciation | 1.7 | 1.5 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 |
| Profit before tax | -5.6 | -6.9 | -5.3 | -3.6 | -5.0 | -5.8 | -5.2 | -5.8 | -7.7 | -8.2 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -5.6 | -6.9 | -5.3 | -3.6 | -5.0 | -5.8 | -5.2 | -5.8 | -7.7 | -8.3 |
| EPS in Rs | -2.58 | -3.07 | -2.47 | -1.66 | -2.31 | -2.72 | -2.4 | -2.67 | -3.59 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 5% |
| 3 Years: | -10% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 1% |
| 3 Years: | 12% |
| TTM: | -37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | -14% |
| 1 Year: | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|